REACTION-KINETICS OF CISPLATIN AND ITS MONOAQUATED SPECIES WITH THE MODULATING AGENTS (DI)MESNA AND THIOSULFATE

被引:32
作者
LEEUWENKAMP, OR
NEIJT, JP
VANDERVIJGH, WJF
PINEDO, HM
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT ONCOL,CLIN RES LAB,DE BOELELAAN 1117,1081 HV AMSTERDAM,NETHERLANDS
[2] UNIV UTRECHT HOSP,DEPT ONCOL,3511 GV UTRECHT,NETHERLANDS
关键词
D O I
10.1016/0277-5379(91)90090-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The reactive and rapidly excreted thiol mesna (2-mercaptoethane-sulphonate sodium) has the potential to reduce the dose-limiting nephrotoxicity of cisplatin by chemical neutralisation of the latter in the kidney. The reaction kinetics of cisplatin with mesna and its disulphide, dimesna, was studied at 37-degrees-C in unbuffered 0.15 mol/l NaCl (pH 5.3) and in 0.15 mol/l NaCl buffered with 0.02 mol/l Hepes (pH 7.4). The reaction mixtures were analysed for intact cisplatin. In the presence of mesna or dimesna 0.5 mol/l as anticipated in urine for conditions of renal protection, the half-life (t1/2) of 0.2 mmol/l cisplatin was less than 6 min. t1/2 of 151 and 629 min were found in the presence of mesna and dimesna concentrations of 5 mmol/l and 3 mmol/l, respectively, anticipated in plasma under conditions of renal protection. Cis-diamminemonoaquamonochloroplatinum(II) 0.2 mmol/l reacted rapidly with 50 mmol thiosulphate and 0.5 mol/l (di)mesna (t1/2 less-than-or-equal-to 1 min). This platinum species also reacted rapidly with 2.6 mmol/l thiosulphate (t1/2 < 1 min), a concentration reached in plasma for conditions under renal protection. Reaction of the monoaquated form of cisplatin proceeded slowly in the presence of dimesna or mesna concentrations (< 5 mmol/l), as anticipated in plasma under renal protecting conditions. It is hypothesised that renal protection by the strong nucleophiles, thiosulphate, mesna and dimesna occurs rather by neutralisation of the aquated species in the lumen of the renal tubulus than by neutralisation of intact cisplatin, and that neutralisation of these species in plasma contributes significantly to the protecting effect.
引用
收藏
页码:1243 / 1247
页数:5
相关论文
共 27 条
[1]  
BURKERT H, 1981, CONTRIBUTIONS ONCOLO
[2]  
CHOPRA S, 1982, KIDNEY INT, V21, P54, DOI 10.1038/ki.1982.8
[3]   CISPLATIN METABOLITES IN PLASMA, A STUDY OF THEIR PHARMACOKINETICS AND IMPORTANCE IN THE NEPHROTOXIC AND ANTITUMOUR ACTIVITY OF CISPLATIN [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (19) :3063-3070
[4]   THE RENAL FRACTIONAL CLEARANCE OF PLATINUM ANTITUMOUR COMPOUNDS IN RELATION TO NEPHROTOXICITY [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (09) :1423-1428
[5]   ANALYSIS OF PLATINUM SPECIES ORIGINATING FROM CIS-DIAMMINEDICHLOROPLATINUM(II) (CISPLATIN) IN HUMAN AND RAT PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ONLINE INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION SPECTROMETRIC DETECTION [J].
DEWAAL, WAJ ;
MAESSEN, FJMJ ;
KRAAK, JC .
JOURNAL OF CHROMATOGRAPHY, 1987, 407 :253-272
[6]  
DOBYAN DC, 1980, J PHARMACOL EXP THER, V213, P551
[7]   INTERACTION BETWEEN CISPLATIN AND MESNA IN MICE [J].
DORR, RT ;
LAGEL, K .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (06) :604-605
[8]   INFLUENCE OF HYDROLYSIS PRODUCTS OF AQUA(1,1-BIS(AMINOMETHYL)CYCLOHEXANE)SULFATOPLATINUM(II) ON TOXICITY IN RATS [J].
ELFERINK, F ;
VANDERVIJGH, WJF ;
VANDERPOORT, SEJM ;
HENZENLOGMANS, SC ;
PINEDO, HM .
CANCER LETTERS, 1984, 25 (01) :61-69
[9]  
ELFERINK F, 1986, CLIN CHEM, V32, P641
[10]  
FOWLER BA, 1983, FED PROC, V42, P2957